1. Home
  2. JBGS vs ORIC Comparison

JBGS vs ORIC Comparison

Compare JBGS & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JBG SMITH Properties

JBGS

JBG SMITH Properties

HOLD

Current Price

$15.58

Market Cap

906.3M

Sector

Real Estate

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$8.82

Market Cap

837.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBGS
ORIC
Founded
2016
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.3M
837.3M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
JBGS
ORIC
Price
$15.58
$8.82
Analyst Decision
Sell
Strong Buy
Analyst Count
1
13
Target Price
$15.00
$19.73
AVG Volume (30 Days)
462.4K
1.4M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
4.69%
N/A
EPS Growth
N/A
19.67
EPS
N/A
N/A
Revenue
$498,598,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.03
$4.65
52 Week High
$24.30
$14.93

Technical Indicators

Market Signals
Indicator
JBGS
ORIC
Relative Strength Index (RSI) 54.81 36.43
Support Level $15.20 $7.90
Resistance Level $16.04 $11.22
Average True Range (ATR) 0.48 0.55
MACD 0.03 -0.09
Stochastic Oscillator 65.15 6.47

Price Performance

Historical Comparison
JBGS
ORIC

About JBGS JBG SMITH Properties

JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: